Loading news...
An aging population and rising AI adoption boost demand in the Zacks Medical - Outpatient and Home Healthcare industry. DGX, DVA, OPCH and ADUS stand to benefit.
Game Creek Capital LP bought a new position in Option Care Health, Inc. (NASDAQ: OPCH) in the undefined quarter, according to its most recent disclosure with the SEC. The firm bought 55,000 shares of the company's stock, valued at approximately $1,527,000. Other hedge funds and other institutional investors also recently modified their holdings
Elo Mutual Pension Insurance Co boosted its holdings in Option Care Health, Inc. (NASDAQ: OPCH) by 81.5% during the undefined quarter, according to the company in its most recent disclosure with the SEC. The fund owned 46,549 shares of the company's stock after buying an additional 20,896 shares during the quarter. Elo Mutual
Option Care Health, Inc. (OPCH) Q4 2025 Earnings Call Transcript
Option Care (OPCH) came out with quarterly earnings of $0.46 per share, in line with the Zacks Consensus Estimate . This compares to earnings of $0.35 per share a year ago.
BANNOCKBURN, Ill., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today financial results for the fourth quarter and full year ended December 31, 2025.
Option Care Health (NASDAQ: OPCH - Get Free Report) is anticipated to issue its Q4 2025 results before the market opens on Tuesday, February 24th. Analysts expect the company to announce earnings of $0.46 per share and revenue of $1.4633 billion for the quarter. Investors are encouraged to explore the company's upcoming Q4 2025 earning overview
Xcelerate (OTCMKTS:XCRT - Get Free Report) and Option Care Health (NASDAQ: OPCH - Get Free Report) are both medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, dividends, earnings, valuation, risk, analyst recommendations and institutional ownership. Volatility and Risk Xcelerate has a beta of
Option Care Health (NASDAQ: OPCH - Get Free Report) and Bioqual (OTCMKTS:BIOQ - Get Free Report) are both medical companies, but which is the better investment? We will compare the two companies based on the strength of their risk, institutional ownership, profitability, earnings, valuation, analyst recommendations and dividends. Valuation and Earnings This table compares Option Care
THC, UHS and OPCH look poised to beat Q4 estimates as volumes, admissions and revenue trends improve.
BANNOCKBURN, Ill., Jan. 29, 2026 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (“Option Care Health”) (Nasdaq: OPCH), the nation's largest independent provider of home and alternate site infusion services, will participate in the 46th Annual TD Cowen Healthcare Conference, being held in Boston, MA, on Tuesday, March 3, 2026, including a fireside chat at 1:10pm ET. The webcast will be available online at https://investors.optioncarehealth.com .
Compass Wealth Management LLC reduced its position in shares of Option Care Health, Inc. (NASDAQ: OPCH) by 98.7% during the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 2,338 shares of the company's stock after selling 182,440 shares during the quarter. Compass Wealth
Option Care (OPCH) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Option Care Health (NASDAQ: OPCH - Get Free Report) and Xcelerate (OTCMKTS:XCRT - Get Free Report) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, profitability, risk, dividends, earnings and analyst recommendations. Valuation and Earnings This table compares Option Care
BANNOCKBURN, Ill., Jan. 21, 2026 (GLOBE NEWSWIRE) -- Option Care Health Inc. (“Option Care Health”) (NASDAQ: OPCH), the nation's largest independent provider of home and alternate site infusion services, today announced that the company will release results for its fourth quarter and full year 2025 on Tuesday, February 24, 2026 before the market opens. In conjunction, the management team will host a conference call to review the results at 8:30 a.m. E.T. on the same day.
Option Care Health, Inc. (NASDAQ: OPCH - Get Free Report) hit a new 52-week high on Wednesday after Morgan Stanley raised their price target on the stock from $35.00 to $38.00. Morgan Stanley currently has an overweight rating on the stock. Option Care Health traded as high as $35.54 and last traded at $35.51, with a
Option Care (OPCH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
It released its preliminary quarterly and full-year 2025 figures. These indicated a healthy year-over-year rise in revenue and a potential bottom-line bump.
Option Care Health, Inc. (OPCH) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
BANNOCKBURN, Ill., Jan. 12, 2026 (GLOBE NEWSWIRE) -- Option Care Health, Inc. (the “Company” or “Option Care Health”) (Nasdaq: OPCH), the nation's largest independent provider of home and alternate site infusion services, announced today preliminary unaudited financial results for the fourth quarter and full year ended December 31, 2025, and preliminary financial guidance for the full year 2026.